This study aimed to explore whether peripheral nesfatin-1 was involved in the pathophysiology in streptozotocin (STZ)-induced T2DM mice and, if so, how nesfatin-1 ameliorated disordered lipid metabolism, whether AMPK in skeletal muscle was a target of peripheral nesfatin-1. The gene discussed is NUCB2; the disease is type 2 diabetes mellitus.